AI Insight
A large-scale study involving nearly 4,000 infants found that acetaminophen and ibuprofen demonstrated equivalent safety profiles during infancy. Neither medication showed associations with eczema or bronchiolitis development, and no serious adverse effects were attributed to either drug. Researchers plan to continue monitoring these children until age six to assess potential long-term health outcomes.
Why it matters
This research provides reassurance to parents and healthcare providers about the safety of these commonly used pain and fever medications in babies. The findings may help inform pediatric care guidelines and reduce parental anxiety around administering these over-the-counter medications to infants.
Understand the Science
A landmark study of nearly 4,000 babies found that acetaminophen and ibuprofen were equally safe during infancy. Neither medicine was linked to eczema or bronchiolitis, and no serious side effects were caused by the drugs. Researchers will continue following the children through age six to study possible long-term effects.
Source: Major study challenges long-held fears about acetaminophen and ibuprofen use in babies